AMRZ:SIXAmrize Ltd Analysis
Data as of 2026-06-14 - not real-time
$53.17
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Amrize Ltd trades around $53, sitting below its 20‑day and 50‑day moving averages while the 200‑day average remains a touch higher, indicating a short‑term pull‑back within a broadly neutral trend. Technical signals are mixed: RSI hovers near the midpoint, MACD shows a bullish crossover with a positive histogram, and volume is stable, but the price is still under pressure at a key resistance near $55.
Fundamentally the stock appears overvalued – the DCF fair‑value estimate is roughly $29, far below the market price, and the forward P/E of ~16.7, while lower than the trailing 25×, still reflects premium valuation for a basic‑materials firm with modest 4‑5% revenue growth, negative operating margins and a debt‑to‑equity ratio above 50. Dividend yield is minimal and the payout ratio is zero, raising questions about sustainability given the high leverage. The company’s exposure to North‑American construction cycles adds sector and geographic cyclicality, while a beta of 1.35 and 30‑day volatility above 40% signal heightened price swings.
Fundamentally the stock appears overvalued – the DCF fair‑value estimate is roughly $29, far below the market price, and the forward P/E of ~16.7, while lower than the trailing 25×, still reflects premium valuation for a basic‑materials firm with modest 4‑5% revenue growth, negative operating margins and a debt‑to‑equity ratio above 50. Dividend yield is minimal and the payout ratio is zero, raising questions about sustainability given the high leverage. The company’s exposure to North‑American construction cycles adds sector and geographic cyclicality, while a beta of 1.35 and 30‑day volatility above 40% signal heightened price swings.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD crossover amid neutral RSI
- Price testing resistance at $55
- High short‑term volatility and beta
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Modest revenue growth and improving forward earnings estimate
- Persistent high leverage and negative operating margin
- Sector cyclicality tied to construction activity
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Significant overvaluation relative to DCF fair value
- Elevated debt load and limited dividend cushion
- Cyclical exposure and high beta amplifying downside risk
Key Metrics & Analysis
Financial Health
Revenue Growth4.70%
Profit Margin9.70%
P/E Ratio25.4
ROE10.08%
ROA4.95%
Debt/Equity54.23
P/B Ratio2.2
Op. Cash Flow$2.2B
Free Cash Flow$1.4B
Technical Analysis
TrendNeutral
RSI51.1
Support$47.80
Resistance$54.68
MA 20$51.93
MA 50$54.08
MA 200$53.85
MACDBullish
VolumeStable
Fear & Greed Index89.86
Valuation
Fair Value$29.27
Target Price$64.91
Upside/Downside22.07%
GradeOvervalued
TypeValue
Dividend Yield0.22%
Risk Assessment
Beta1.35
Volatility43.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.